enquiry@dsij.in |+91 9240904920
SENSEX-307.24
76,957.27-0.4%

UPL margin expansion offsets weather softness as diversified businesses strengthen FY27 growth outlook

UPL Ltd.

Broker Recommendation:

HOLD

Broker: Motilal Oswal Financial Services Ltd.

03 Aug 2026

Sector: Chemicals

Reco. Price

₹620

CMP

₹562.5

Target

₹600

Downside

3.23%

Investment View and First-Quarter FY27 Performance

Motilal Oswal Financial Services retained its Neutral rating on UPL Ltd after a strong first-quarter FY27 operating performance. The broker highlighted broad-based growth, price increases, a favourable product mix and operational efficiencies. The target price remains Rs 600, compared with the CMP of Rs 620.

Metric Q1 FY27 Year-on-year change Broker estimate / comparison
Revenue Rs 10,180 crore 10.5% growth In line with estimate
EBITDA Rs 1,610 crore 23% growth Above Rs 1,510 crore estimate
EBITDA margin 15.8% Expanded 160 basis points
Adjusted profit after tax Rs 160 crore Versus estimated loss of Rs 14.4 crore

Revenue growth comprised a 3% volume decline, 3% price growth and a 10% foreign-exchange benefit. Adjusted profit after tax excludes exchange differences and exceptional items, including restructuring costs.

Regional and Business Performance

Regional performance was mixed but generally positive. In India, revenue rose 15% year on year to Rs 2,600 crore as pricing gains offset monsoon-related volume softness. North America revenue grew 18% to Rs 1,580 crore, led by herbicides, fungicides, post-harvest and aquatic businesses.

Region / business Revenue / performance Key drivers or commentary
India Rs 2,600 crore; 15% growth Pricing gains offset monsoon-related volume softness
North America Rs 1,580 crore; 18% growth Herbicides, fungicides, post-harvest and aquatic businesses
Latin America Rs 2,600 crore; 8% growth Brazil drove growth, while Argentina remained weak
Europe Rs 1,600 crore; 4% growth Currency movements and pricing discipline
Rest of World 7% growth Led by Indonesia and South Asia
UPL Corp 7% growth
Advanta Rs 1,750 crore; 26% growth Growth supported by seeds
Superform 14% growth Specialty mix reached 29% of revenue versus 26% at FY26-end
Specialty Chemicals 51% growth Supported by 17% volume growth and 34% pricing growth

FY27 Outlook and Growth Drivers

Management reiterated its FY27 guidance for revenue growth of 7–11% and EBITDA growth of 10–14%, despite weather disruption and geopolitical uncertainty. It expects a stronger, volume-led second quarter FY27 as seasonal demand and new launches contribute.

  • Management targets approximately USD 115 million of FY27 revenue from new products.
  • Sustainable Solutions revenue is targeted at approximately USD 700 million.
  • Advanta's growth is expected to remain supported by seeds.
  • Super Specialty Chemicals is expected to sustain strong momentum.
  • Superform's specialty mix is targeted to reach a 55:45 Ag-to-Super Specialty mix over the next three to four years through niche technology platforms, contract manufacturing and higher-value specialty chemistries.

Balance Sheet and Cash Conversion

Net debt stood at Rs 23,600 crore at June 2026, compared with Rs 21,370 crore at June 2025 and Rs 15,300 crore at March 2026. Gross debt reduced by more than USD 100 million quarter on quarter to USD 3.0 billion. Net debt to EBITDA improved to 2.4 times from 2.6 times year on year.

Management remains committed to a medium-term net debt-to-EBITDA target below 1.5 times. It has also refinanced the USD 400 million September 2026 maturity for three additional years. However, net working-capital days increased to 110 because of an inventory and receivables build-up, while first-quarter FY27 operating cash flow was negative at Rs 2,690 crore.

Earnings Estimates and Valuation

Motilal Oswal expects UPL's FY26–28E revenue, EBITDA and adjusted profit after tax to compound at 8%, 9% and 28%, respectively.

Estimate Revised FY27E Revision
Revenue Rs 56,400 crore Increased 1%
EBITDA Rs 11,100 crore Increased 2%
Adjusted profit after tax Rs 3,500 crore Increased 5%

The broker retained its Rs 600 target price, based on 12 times price-to-earnings, representing a 45% discount to UPL's five-year average multiple. Its positive thesis rests on pricing discipline, premiumisation, market-share gains, innovation, higher-margin businesses and deleveraging.

Key Risks and Constraints

  • Adverse weather and weak crop-protection volumes.
  • Fragile demand in Argentina and Colombia.
  • Supply-chain disruption.
  • Energy and raw-material inflation linked to the Middle East conflict.
  • Seasonal working-capital pressure.
  • Potential normalisation of the 8–10% EBITDA growth benefit from timing-related pricing actions.
View / Download Original Research Report

Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.